WallStSmart

Elevance Health Inc (ELV)vsEnbridge Inc (ENB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Elevance Health Inc generates 190% more annual revenue ($200.42B vs $69.05B). ENB leads profitability with a 10.0% profit margin vs 2.6%. ELV appears more attractively valued with a PEG of 1.47. ELV earns a higher WallStSmart Score of 56/100 (C).

ELV

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 5.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.66

ENB

Buy

55

out of 100

Grade: C

Growth: 5.3Profit: 6.0Value: 3.3Quality: 3.0
Piotroski: 2/9Altman Z: 0.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELVUndervalued (+4.5%)

Margin of Safety

+4.5%

Fair Value

$416.35

Current Price

$415.53

$0.82 discount

UndervaluedFair: $416.35Overvalued
ENBSignificantly Overvalued (-18.9%)

Margin of Safety

-18.9%

Fair Value

$46.85

Current Price

$56.74

$9.89 premium

UndervaluedFair: $46.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELV4 strengths · Avg: 8.3/10
Market CapQuality
$87.28B9/10

Large-cap with strong market position

P/E RatioValuation
17.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$4.10B8/10

Generating 4.1B in free cash flow

ENB3 strengths · Avg: 8.3/10
Market CapQuality
$121.59B9/10

Large-cap with strong market position

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
20.8%8/10

Revenue surging 20.8% year-over-year

Areas to Watch

ELV3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Profit MarginProfitability
2.6%3/10

2.6% margin — thin

EPS GrowthGrowth
-16.8%2/10

Earnings declined 16.8%

ENB4 concerns · Avg: 3.0/10
P/E RatioValuation
26.5x4/10

Moderate valuation

Debt/EquityHealth
1.693/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
5.272/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : ELV

The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bull Case : ENB

The strongest argument for ENB centers on Market Cap, Price/Book, Revenue Growth. Revenue growth of 20.8% demonstrates continued momentum.

Bear Case : ELV

The primary concerns for ELV are Revenue Growth, Profit Margin, EPS Growth. Thin 2.6% margins leave little buffer for downturns.

Bear Case : ENB

The primary concerns for ENB are P/E Ratio, Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

ELV profiles as a value stock while ENB is a growth play — different risk/reward profiles.

ENB carries more volatility with a beta of 0.81 — expect wider price swings.

ENB is growing revenue faster at 20.8% — sustainability is the question.

ELV generates stronger free cash flow (4.1B), providing more financial flexibility.

Bottom Line

ELV scores higher overall (56/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Enbridge Inc

ENERGY · OIL & GAS MIDSTREAM · USA

Enbridge Inc. is an energy infrastructure company. The company is headquartered in Calgary, Canada.

Want to dig deeper into these stocks?